Chronic inflammation is now understood to be the underlying driver of nearly every major disease — from cardiovascular disease and diabetes to autoimmune conditions, cancer risk, and neurodegeneration. It's also one of the primary mechanisms behind fatigue, brain fog, and the general feeling that your body just isn't running the way it should.
Peptide therapy for immune optimization doesn't suppress your immune system — it rebalances and regulates it. The goal is a system that responds powerfully when it needs to, and stands down when it doesn't. That's the difference between optimized immunity and a chronically inflamed one.
Our protocols are built around two of the most clinically studied immune-active peptides available: Thymosin Alpha-1, a master immune regulator, and BPC-157, a powerful anti-inflammatory healing compound. Used together, they address both the adaptive and innate arms of your immune system — a comprehensive approach that standalone supplements simply can't replicate.
What Is Thymosin Alpha-1?
Thymosin Alpha-1 is a naturally occurring peptide originally isolated from the thymus gland — the organ responsible for producing and maturing the T-cells that coordinate your entire immune response. TA-1 is the thymus gland’s primary immune signaling molecule, and its production declines significantly with age as the thymus shrinks.
Synthetic Thymosin Alpha-1 has been FDA-approved in over 35 countries for treating hepatitis B, hepatitis C, and certain cancers. It is used by physicians worldwide as one of the most powerful immune modulators in peptide medicine. It doesn’t merely stimulate the immune system — it educates it, helping the body distinguish between genuine threats and harmless tissue, which makes it uniquely valuable for autoimmune and chronic inflammatory conditions.
What Thymosin Alpha-1 Does
Why BPC-157 Belongs in an Immune Protocol
While BPC-157 is best known for its role in physical recovery and injury repair (see the full BPC-157 page), it is also one of the most potent anti-inflammatory peptides in clinical use — and inflammation is the immune system’s primary output when dysregulated.
BPC-157 works on the gut-immune axis: approximately 70% of the immune system is housed in and around the gastrointestinal tract. By healing the intestinal lining, reducing gut inflammation, and restoring the mucosal barrier, BPC-157 directly reduces the immune system’s chronic activation load — giving Thymosin Alpha-1 a cleaner environment to work in.
BPC-157’s Immune-Specific Benefits
For patients with chronic inflammatory conditions, autoimmune disease, or gut-related immune dysfunction, BPC-157 is a critical part of a complete immune protocol — not an afterthought.
THE COMBINED PROTOCOL — WHY BOTH PEPTIDES TOGETHER
Thymosin Alpha-1 and BPC-157 work on different but complementary aspects of immune health. TA-1 regulates and educates the immune system from the top down — improving how your body identifies and responds to threats. BPC-157 addresses the inflammatory environment from the bottom up — reducing the chronic inflammation that keeps the immune system perpetually overactivated.
Together, they create a full-spectrum immune optimization protocol:
What Patients Experience with Immune Optimization Therapy
Our immune optimization protocols are designed for patients who recognize that their immune system isn’t working optimally — whether that shows up as frequent illness, chronic inflammation, autoimmune disease, or post-viral fatigue. Specifically, our patients include:
Our providers conduct a full intake evaluation — including review of current medications, health conditions, and lab work — before initiating any protocol. If you are on immunosuppressant medications, have an active autoimmune flare, or are currently being treated for cancer, please disclose this during your consultation.
If you’ve been searching for immune optimization therapy near [City], Mardi Gras Wellness offers physician-supervised peptide protocols built around two of the most clinically validated immune peptides available — Thymosin Alpha-1 and BPC-157.
Most people think of immune support as vitamin C, zinc, and elderberry. Those are maintenance tools. What we offer at Mardi Gras Wellness is a fundamentally different approach: using your body’s own molecular language — peptides — to recalibrate how your immune system is functioning at a cellular and regulatory level.
Thymosin Alpha-1 has been studied for decades in clinical settings across more than 35 countries. It is one of the few peptides with a robust clinical track record for immune regulation — not just stimulation. For patients with autoimmune conditions, chronic inflammatory disease, post-viral fatigue, or simply an immune system that’s been under chronic stress, TA-1 offers a path to genuine recalibration.
BPC-157 addresses the gut-immune connection that conventional medicine frequently overlooks. When the intestinal barrier is compromised — as it is in the majority of patients with chronic inflammation — the immune system is perpetually activated by gut contents that shouldn’t be crossing into circulation. BPC-157 repairs that barrier, dramatically reducing the immune system’s background inflammatory load.
Our [City] medical team will evaluate your lab work, symptom history, and health goals before designing a personalized immune optimization protocol. Most patients begin to notice measurable improvements within 4–8 weeks.
SAFETY & SIDE EFFECTS
Both Thymosin Alpha-1 and BPC-157 have excellent safety profiles with decades of clinical research behind them. Side effects are rare and mild.
Thymosin Alpha-1 (TA-1) is a peptide naturally produced by the thymus gland that regulates and activates T-cells — the immune cells responsible for fighting viruses, bacteria, and abnormal cells. It has been approved and used clinically in over 35 countries for immune conditions including hepatitis B, hepatitis C, and certain cancers.
Thymosin Alpha-1 is approved in 35+ countries and used widely under physician supervision in the United States as a research peptide with extensive clinical documentation. It is prescribed off-label by licensed providers including our team at Mardi Gras Wellness.
TA-1 is administered via subcutaneous injection, typically twice weekly for an initial loading phase of 4–12 weeks, followed by a maintenance schedule determined by your provider based on your response and goals.
BPC-157 reduces systemic inflammation and heals the gut lining — the site of approximately 70% of the body's immune activity. By repairing the intestinal barrier and reducing gut-driven immune activation, BPC-157 dramatically lowers the immune system's chronic inflammatory burden, allowing Thymosin Alpha-1 to work in a cleaner internal environment.
Many of our patients with autoimmune conditions report significant improvements in inflammatory markers and symptom frequency. Thymosin Alpha-1's immune-modulating (not immune-stimulating) mechanism makes it particularly relevant for autoimmune patients. However, we always coordinate with your existing care team and review your medications before initiating a protocol.
Most patients notice early improvements in energy, sleep, and acute illness recovery within 3–4 weeks. Measurable reduction in inflammatory markers and autoimmune symptom frequency typically develops over 6–12 weeks of consistent therapy.
Yes. Immune optimization protocols are commonly combined with NAD+ (for cellular energy and further anti-inflammatory effects) and hormone optimization. Your provider will review your full health picture and design a comprehensive protocol where appropriate.
Peptide therapy is typically not covered by standard insurance plans and is offered as a cash-pay service. Our team will provide transparent pricing during your consultation. Flexible payment options may be available.
